Performance analysis of Regentis Biomaterials (RGNT)
Annual Return
Since Dec 4, 2025, RGNT has had an average annual return of -73.33%, underperforming the benchmark SPY, which returned +9.33% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -70.32% | -10.13% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.95% | -31.66% | -22.93% | -4.74% | -36.42% | +90.80% | -43.34% | -70.32% | |||||
| 2025 | -10.13% | -10.13% |
Drawdown analysis of Regentis Biomaterials (RGNT)
The maximum drawdown for the RGNT was -83.37%, occurring on Jun 8, 2026. Recovery took 5 trading sessions.
The current RGNT drawdown is -78.72%.
Since Dec 4, 2025 RGNT has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -83.37% | Jan 15, 2026 | 98 | Jun 8, 2026 | 5 | Jun 15, 2026 | 103 |
| -78.72% | Jun 15, 2026 | 23 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |
| -19.33% | Dec 4, 2025 | 8 | Dec 16, 2025 | 20 | Jan 15, 2026 | 28 |